Dr. Weeks’ Comment: Dipyridamole is a well known, old and now off patent drug which has been noted to potentiate chemotherapy. It is safe and […]
Safe and effective for cancer, not patentable, cheap = not news. Read More »
SOURCE http://www.anh-usa.org/hot-chemo-acceptable-cancer-treatment/ Why is “Hot Chemo” an Acceptable Cancer Treatment””But IV Vitamin C is “Too Far Out There”? January 31, 2012 Patients liken hot
Hot chemotherapy “almost no basis in science” Read More »
Dr. Weeks’ Comment: even Dr. Wicha recommends to patients with cancer: “see if you are eligible for a clinical trial” as regards treatment for
HDACi and Sodium Butyrate for cancer STEM cells Read More »
Dr. Weeks’ Comment: the PET CT gives not just the size and location but also the activity of the cancer. This is important data. Why
Ask for the PET/CT when they offer the CT Read More »
Dr. Weeks’ Comment: sodium butyrate is a potent under-utilized anti-cancer agent. Ask your oncologists about this potent anti-inflammatory agent. http://www.springerlink.com/content/u208lk865488q787/ Nephrol Dial Transplant. 2012
Sodium Butyrate – cheap cancer killer. Read More »
Dr. Weeks’ Comment: Despite FDA attempting to demonize Sodium Butyrate, guess what? It inhibits cancer STEM cells… Sodium Butyrate Inhibits the Self-Renewal Capacity
Sodium butyrate suppresses cancer STEM cells Read More »
Dr. Weeks’ Comment: Dr. Wicha is leading the revolution in oncology – ask your oncologist if he or she is up to speed as regards
Blocking the Cancer STEM cells Read More »
Drug-induced Senescence Generates Chemoresistant Stemlike Cells with Low Reactive Oxygen Species* Santhi Achuthan et al Abstract Tumor recurrence after chemotherapy or radiation remains a major
How Chemo and Radiation create resistant and aggressive cancer cells Read More »
Differentiation Therapy: Targeting Human Renal Cancer Stem Cells with Interleukin 15 Accepted September 30, 2011. Journal National center Institute Sandy Azzi, et al Background Many renal cancer
The future of treatment for renal cell cancer – get the cancer STEM cells Read More »
EpCAM/CD3-Bispecific T-cell Engaging Antibody MT110 Eliminates Primary Human Pancreatic Cancer Stem Cells . Michele Cioffi1, Jorge Dorado1, Patrick A. Baeuerle2, and Christopher Heeschen1 + Purpose:
the future of treatment for pancreatic cancer – kill the STEM cells Read More »